#USA #Washington #Lung Cancer #LUNGevity Foundation #LungXperience

LUNGevity Foundation Teams Up for the 2025 LungXperience Tour

In an ambitious move to raise awareness about lung health, LUNGevity Foundation, the leading nonprofit organization focusing on lung cancer, has announced its involvement in the 2025 LungXperience Tour. This unique nationwide initiative aims to educate communities about lung cancer screening and the significance of lung health, featuring 12 major events across the United States. This effort is made possible through a valuable partnership with AstraZeneca and Kroger Health.

Exploring the LungXperience Exhibit

At the heart of this initiative is an eye-catching 20'x20' inflatable exhibit modeled after human lungs. Visitors have the rare chance to walk through this stunning structure, which provides an interactive exploration of lung anatomy. This educational segment is designed to inform attendees about the various risk factors associated with diseases like lung cancer and Chronic Obstructive Pulmonary Disease (COPD). More significantly, it emphasizes the life-saving advantages of early lung cancer screening.

Arun Krishna, the Vice President and Head of US Oncology for Lung Cancer at AstraZeneca, expressed enthusiasm about the partnership, stating, "Our team is deeply committed to eliminating lung cancer as a cause of death for every patient at every stage—and we're excited to support the LungXperience as it drives important conversations about lung health across the country."

Importance of Early Detection

Andrea Ferris, President and CEO of LUNGevity, emphasized the critical nature of early detection. "Early detection saves lives, and programs like LungXperience are crucial for reaching people where they are," she stated. The initiative specifically targets underserved communities that may have limited access to healthcare resources. Through this presence at various events, LUNGevity not only educates individuals about lung health but also underscores the importance of timely lung screenings and provides support resources.

What LUNGevity Offers at Events

During the LungXperience tour, LUNGevity will engage with the public by distributing:

• - Comprehensive educational materials detailing lung cancer risks, symptoms, and screening processes.
• - Information on available clinical trials and early detection techniques.
• - Interactive engagement opportunities with LUNGevity staff and volunteers.
• - Access to digital resources and tools through QR codes and giveaways to enhance awareness.

The tour will showcase LUNGevity at various high-footfall events including NASCAR races, state fairs, and more—reaching an anticipated audience exceeding one million people. The organization will be present at twelve selected events in the upcoming months, including:
1. Indianapolis Motor Speedway (July 25–27)
2. Ohio State Fair (July 31–August 3)
3. Richmond International Raceway (August 15–16)
4. Tennessee State Fair (August 20 – 23)
5. NHRA Indianapolis (August 29–31)
6. Chicago Oktoberfest (September 5-7)
7. Kansas State Fair (September 11–14)
8. Kroger Health Wellness Festival in Cincinnati (September 26–27)
9. Charlotte Motor Speedway, Kroger Store (October 3)
10. Las Vegas Motor Speedway (October 10-12)
11. Phoenix Raceway (October 31 – November 2)
12. NHRA Finals, Pomona (November 13-16)

For those interested in learning more about LUNGevity's mission or for details about the full tour schedule, further information can be found at www.LUNGevity.org.

About LUNGevity Foundation

As the foremost lung cancer organization in the United States, LUNGevity Foundation seeks to redefine the journey and management of lung cancer. Their mission encompasses immediate improvements in quality of life for individuals impacted by the disease while tackling health equity challenges in care provision.

They prioritize research aimed at early diagnosis, advocating for breakthroughs in treatment and ensuring access to screening and biomarker testing for all individuals. Their comprehensive resources range from a medically vetted website tailored for lung cancer patients to a helpline offering personalized support and connections to clinical trials. Through their relentless initiatives, LUNGevity is poised to realize its vision—creating a world where lung cancer no longer leads to fatalities.

The Statistics on Lung Cancer in the United States

According to recent data, roughly 1 in 18 Americans will face a lung cancer diagnosis during their lifetime. This year alone, over 234,000 Americans are expected to be diagnosed, translating to a new diagnosis every 2.2 minutes. Alarmingly, about 65% of these cases occur in individuals with no significant tobacco exposure, and lung cancer remains the leading cause of cancer deaths, outpacing colorectal and pancreatic cancers combined. While only 27% of lung cancer patients survive for five years or more, early-stage intervention significantly boosts those odds to 64%.

In summary, the 2025 LungXperience Tour led by LUNGevity Foundation is more than a series of events; it represents a crucial step towards enhancing awareness, securing equity in healthcare, and rallying community support around lung health and early detection strategies.